Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies
- PMID: 16956468
- DOI: 10.2310/6620.2006.05053
Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies
Abstract
A 60-year-old man developed a bullous contact dermatitis after topical corticosteroid treatment of dermatitis on his lower leg. Subsequent patch testing showed cross-reactions to numerous group B and group D corticosteroids as well as cross-reactions to group C desoximetasone and group D1 mometasone furoate. His patch-test result was negative for the group A corticosteroids hydrocortisone and tixocortol pivalate. We discuss the uncommon finding of cross-reactions to desoximetasone and mometasone furoate.
Similar articles
-
Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.Contact Dermatitis. 1996 Mar;34(3):161-4. doi: 10.1111/j.1600-0536.1996.tb02166.x. Contact Dermatitis. 1996. PMID: 8833457
-
Multiple corticosteroid allergies.Australas J Dermatol. 2001 Feb;42(1):62-3. doi: 10.1046/j.1440-0960.2001.00478.x. Australas J Dermatol. 2001. PMID: 11233727
-
Cross-sensitization to mometasone furoate in patients with corticosteroid contact allergy.Contact Dermatitis. 1992 Nov;27(5):323-5. doi: 10.1111/j.1600-0536.1992.tb03290.x. Contact Dermatitis. 1992. PMID: 1493689 No abstract available.
-
Once-a-day topical corticosteroids.Drug Ther Bull. 1995 Mar;33(3):21-2. doi: 10.1136/dtb.1995.33321. Drug Ther Bull. 1995. PMID: 7587987 Review. No abstract available.
-
Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis.Expert Opin Pharmacother. 2003 Sep;4(9):1579-91. doi: 10.1517/14656566.4.9.1579. Expert Opin Pharmacother. 2003. PMID: 12943488 Review.
Cited by
-
Development and Validation of a Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Phenoxyethanol, Methylparaben, Propylparaben, Mometasone Furoate, and Tazarotene in Topical Pharmaceutical Dosage Formulation.Sci Pharm. 2013 Jun 4;81(4):951-67. doi: 10.3797/scipharm.1303-22. Print 2013 Oct-Dec. Sci Pharm. 2013. PMID: 24482766 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources